Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
06/1995
06/29/1995WO1995015161A3 Medicament for treating heart insufficiency
06/29/1995WO1995011013A3 Combination of progesterone antagonists and anti-oestrogens with partial agonistic action for use in hormone-replacement therapy for peri- and post-menopausal women
06/29/1995DE4345266A1 New isoquinolone or phthalazinone carboxylic acid ester and derivs.
06/29/1995CA2179606A1 Macrophage inflammatory proteins-3, -4 and -1.gamma.
06/29/1995CA2179399A1 4,5-diaryloxazole derivatives
06/29/1995CA2179067A1 Polymorphs of losartan and the process for the preparation of form ii of losartan
06/29/1995CA2178209A1 Anellated dihydropyridines and the use thereof for preparing pharmaceutical preparations
06/29/1995CA2178094A1 New pyridazino[4',5':3,4]pyrrolo-[2,1-a]isoquinolines and their use for preparing pharmaceutical compositions
06/29/1995CA2178088A1 Anellated dihydropyridines and their use in the production of pharmaceutical preparations
06/29/1995CA2177851A1 Heterocyclic compounds
06/28/1995EP0659761A2 New 17-iminomethylalkenyl-5beta-14beta-androstane and 17-iminoalkyl-5beta-14beta-androstane derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same
06/28/1995EP0659748A1 Substituted 1-oxo-1,2-dihydro-isoquinolinoyl-and 1,1-dioxo-2H-1,2-benzothiazinoylguanidines, process for their preparation, their use as medicament or diagnostic agent, as well as a medicament containing them
06/28/1995EP0659747A1 Branched aminothiazole derivatives process for their preparation and pharmaceutical compositions containing them
06/28/1995EP0659426A1 2-Phenyl-3-azoylbenzothiophenes for treating pulmonary hypertensive diseases
06/28/1995EP0659415A2 Inhibition of vasomotor symptoms and treatment of psychological disturbances surrounding post-menopausal syndrome
06/28/1995EP0659213A1 Growth hormone antagonists
06/28/1995EP0659183A1 Heteroaryl compounds used as pharmaceuticals
06/28/1995EP0659174A1 Derivatives of valproic and 2-valproenoic acid amides and use as anticonvulsants
06/28/1995EP0466909B1 Thyroid hormone for cardiac treatment
06/27/1995US5428158 2-substituted indane-2-mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
06/27/1995US5428157 3-acylaminobenzodiazepines
06/27/1995US5428064 N-phenyl-amino-terminated non-peptidyl α-succinamidoacyl aminodiolsas anti-hypertensive agents
06/27/1995US5428054 Renin inhibitor
06/27/1995US5428046 Acylsulfonamido- and sulfonamidopyridine-2-carboxylic acid esters and their pyridine N-oxides, processes for their preparation and their use as medicaments
06/27/1995US5428042 1-(2H-1-oxo-3,4-dihydronaphtyl-6-yl)-acetyl-piperidines as kappa agonists
06/27/1995US5428037 Heterocyclic derivatives in the treatment of Ischaemia and related diseases
06/27/1995US5428031 Benzodiazepine analogs; cardiovascular disorders
06/27/1995US5428028 Method for lowering cholesterol employing a phosphonomethylphosphinate squalene synthetase inhibitor
06/27/1995US5428021 Human leukocyte elastase (HLE) inhibitors, and related pharmaceutical compositions and methods of use
06/27/1995US5427797 Anticoagulants; therapy for respiratory system disorders
06/27/1995CA1336099C Urea based lipoxygenase compounds
06/25/1995CA2138466A1 Substituted 1-oxo-1,2-dihydroisoquinolinoylguanidines and 1,1-dioxo-2h-1,2-benzothiazinoylguanidines, a process for their preparation, their use as a medicament or diagnostic agent, and also a medicament containing them
06/22/1995WO1995016690A1 PYRANO[f]QUINOLINE DERIVATIVE AND MEDICINAL COMPOSITION CONTAINING THE SAME AS ACTIVE INGREDIENT
06/22/1995WO1995016679A1 Morpholine and thiomorpholine tachykinin receptor antagonists
06/22/1995WO1995016672A1 Vitamin d amine and amide derivatives
06/22/1995WO1995016661A1 Salts of a polyunsaturated fatty acid and pharmaceutical formulations containing them
06/22/1995WO1995016466A1 Antisense oligonucleotides to suppress eicosanoid formation
06/22/1995WO1995016442A1 Novel potassium channel agonist produced from trichoderma virens
06/22/1995WO1995010271A3 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders
06/22/1995CA2179168A1 Antisense oligonucleotides to suppress eicosanoid formation
06/22/1995CA2179068A1 Novel potassium channel agonist produced from trichoderma virens
06/22/1995CA2178090A1 Vitamin d amine and amide derivatives
06/22/1995CA2138638A1 Branched-amino-substituted thiazoles, processes for their preparation and the pharmaceutical compositions which contain them
06/22/1995CA2138508A1 Methods for inhibiting ldl oxidation and atherosclerosis
06/22/1995CA2138499A1 Methods for inhibiting vasomotor symptoms and attending psychological disturbances surrounding post-menopausal syndrome
06/22/1995CA2138496A1 Methods of inhibiting pulmonary hypertensive diseases
06/22/1995CA2138454A1 Methods of inhibiting imperfect tissue repair
06/21/1995EP0658553A1 Polycyclic aromatic compounds, pharmaceutical compositions containing them and uses thereof
06/21/1995EP0658552A1 Process for the preparation of alpha-tocopherol derivatives
06/21/1995EP0658539A1 Excitatory amino acid receptor antagonists
06/21/1995EP0658538A1 Diagnosis, evaluation and treatment of coronary artery disease by exercise simulation using closed loop drug delivery of an exercise simulating agent beta agonist
06/21/1995EP0658209A1 Endothelial lineage specific transcriptional regulatory element from tek
06/21/1995EP0658205A1 Lipoprotein associated phospholipase a 2?, inhibitors thereof and use of the same in diagnosis and therapy
06/21/1995EP0658169A1 Diamino acid derivatives as antihypertensives
06/21/1995EP0658161A1 Substituted thiazolidinedione derivatives
06/21/1995CN1103781A Use of phenalkylamines
06/21/1995CN1028992C 1,4-Benzothiazepine derivatives
06/21/1995CN1028991C Tetrahydronaphthalene derivatives
06/21/1995CN1028962C Stabilization medicines, process for producing them and slabilization pharmaceutical composition
06/20/1995US5426226 Intermediates for making ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes and 3-aminochromanes
06/20/1995US5426185 Antiarrhythmia agents having reduced side effects
06/20/1995US5426179 Substituted androstanes
06/20/1995US5426122 Methods for reducing blood pressure with dimercaptosuccinic acid (DMSA)
06/20/1995US5426119 Thromboxane antagonists
06/20/1995US5426117 N-methyl-2-(3-pyridyl)-tetrahydrothio-pyran-2-carbothioamide 1-oxide to the preparation of medicinal products intended for treatment of coronary insufficiency
06/20/1995US5426107 Pyrazolopyrimidinone antianginal agents
06/20/1995US5426103 Certain macrocyclic lactam derivatives
06/20/1995CA1335989C Substituted 3-aminosydnone imines, a process for their preparation and their use
06/16/1995CA2137897A1 Biaromatic compounds derived from amides; pharmaceutical and cosmetic compositions containing the same and their uses
06/16/1995CA2137739A1 Polycyclic aromatic compounds; pharmaceutical and cosmetic compositions containing the same and their use
06/15/1995WO1995016033A1 C5a RECEPTOR ANTAGONISTS HAVING SUBSTANTIALLY NO AGONIST ACTIVITY
06/15/1995WO1995015979A1 Pretargeting methods and compounds
06/15/1995WO1995015963A1 Bicyclene derivatives, their production and use
06/15/1995WO1995015961A1 Bicyclic heterocycles as neurokinin a antagonists
06/15/1995WO1995015957A1 Chroman derivative
06/15/1995WO1995015954A1 Heterocyclic biphenylylamides useful as 5ht1d antagonists
06/15/1995WO1995015749A1 Cysteine protease inhibitors containing heterocyclic leaving groups
06/15/1995WO1995009619A3 Substituted urea and isothiourea derivatives as no synthase inhibitors
06/15/1995CA2178476A1 Pretargeting methods and compounds
06/15/1995CA2177495A1 Cysteine protease inhibitors containing heterocyclic leaving groups
06/15/1995CA2176825A1 C5a receptor antagonists having substantially no agonist activity
06/15/1995CA2175701A1 Bicyclic heterocycles as neurokinin a antagonists
06/15/1995CA2137481A1 Process for the preparation of .alpha.-tocopherol derivatives
06/14/1995EP0657458A1 Protein kinase C inhibitors
06/14/1995EP0657454A1 Imidazopyridazines being angiotensin II antagonists
06/14/1995EP0657453A1 Angiotensin converting enzyme (ace) inhibitors containing a fused multiple ring lactam
06/14/1995EP0657452A1 Imidazopyridines
06/14/1995EP0657435A2 1,2-Dihydro-2-oxo-pyrimidines
06/14/1995EP0657433A1 Dihydropyridines with substituted esters showing cerebral activity
06/14/1995EP0657431A1 4-Phenyl-3-substituted 1,4-dihydropyridine esters with cerebral activity
06/14/1995EP0657430A1 Isopropyl-(2-methoxyethyl)-4-(2-chloro-3-cyano-phenyl)-1,4-dihydro-2,6-dimethyl-piridine-3,5-dicarboxylate
06/14/1995EP0657426A2 Tricyclic pyrrole derivatives
06/14/1995EP0657423A1 Aminosubstituted benzoylsulfonylurea and thiourea derivatives, process for their preparation and their use as pharmaceuticals
06/14/1995EP0657162A1 Methods for lowering serum cholesterol
06/14/1995EP0657029A1 Calcium receptor active molecules
06/14/1995EP0656897A1 Quinuclidine derivatives as squalene synthase inhibitors
06/14/1995EP0656881A1 Ester and combinations of an organic nitrate and a salicylate
06/14/1995EP0656844A1 Crank mechanism for a windscreen wiper drive of a motor vehicle.
06/14/1995EP0525111B1 Antiinflammatory hydroxamic acids and n-hydroxyureas
06/14/1995CN1103580A New use
1 ... 1426 1427 1428 1429 1430 1431 1432 1433 1434 1435 1436 1437 1438 1439 1440 1441 1442 1443 1444 1445 1446 ... 1595